These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 18160317)

  • 1. Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del "loss of function" mutations in ferroportin disease.
    Lim FL; Dooley JS; Roques AW; Grellier L; Dhillon AP; Walker AP
    Blood Cells Mol Dis; 2008; 40(3):328-33. PubMed ID: 18160317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
    Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
    Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features.
    Sham RL; Phatak PD; West C; Lee P; Andrews C; Beutler E
    Blood Cells Mol Dis; 2005; 34(2):157-61. PubMed ID: 15727899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and clinical heterogeneity of ferroportin disease.
    Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M
    Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited iron export by hepatocytes contributes to hepatic iron-loading in the Hfe knockout mouse.
    Chua AC; Drake SF; Herbison CE; Olynyk JK; Leedman PJ; Trinder D
    J Hepatol; 2006 Jan; 44(1):176-82. PubMed ID: 16271796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic expression of ferroportin disease in a family with the N144H mutation.
    Rosmorduc O; Wendum D; Arrivé L; Elnaggar A; Ennibi K; Hannoun L; Charlotte F; Grangé JD; Poupon R
    Gastroenterol Clin Biol; 2008 Mar; 32(3):321-7. PubMed ID: 18403150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients.
    Grigg AP; Bhathal PS
    Pathology; 2001 Feb; 33(1):44-9. PubMed ID: 11280607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroportin-1 in the recurrence of hepatic iron overload after liver transplantation.
    Valenti L; Guido M; Dongiovanni P; Cremonesi L; Fracanzani AL; Fargion S
    Dig Liver Dis; 2009 Jul; 41(7):e17-20. PubMed ID: 18337195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
    Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
    Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional consequences of ferroportin 1 mutations.
    Liu XB; Yang F; Haile DJ
    Blood Cells Mol Dis; 2005; 35(1):33-46. PubMed ID: 15935710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for hemochromatosis in asymptomatic subjects with or without a family history.
    Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML
    Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
    Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM
    Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases.
    Létocart E; Le Gac G; Majore S; Ka C; Radio FC; Gourlaouen I; De Bernardo C; Férec C; Grammatico P
    Br J Haematol; 2009 Nov; 147(3):379-85. PubMed ID: 19709084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel ferroportin mutation in a Canadian family with autosomal dominant hemochromatosis.
    Morris TJ; Litvinova MM; Ralston D; Mattman A; Holmes D; Lockitch G
    Blood Cells Mol Dis; 2005; 35(3):309-14. PubMed ID: 16111902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired iron transport activity of ferroportin 1 in hereditary iron overload.
    McGregor JA; Shayeghi M; Vulpe CD; Anderson GJ; Pietrangelo A; Simpson RJ; McKie AT
    J Membr Biol; 2005 Jul; 206(1):3-7. PubMed ID: 16440176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G80S-linked ferroportin disease: the first clinical description in a Greek family.
    Mougiou A; Pietrangelo A; Caleffi A; Kourakli A; Karakantza M; Zoumbos N
    Blood Cells Mol Dis; 2008; 41(1):138-9. PubMed ID: 18420432
    [No Abstract]   [Full Text] [Related]  

  • 17. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.
    Aigner E; Theurl I; Haufe H; Seifert M; Hohla F; Scharinger L; Stickel F; Mourlane F; Weiss G; Datz C
    Gastroenterology; 2008 Aug; 135(2):680-8. PubMed ID: 18505688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
    Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
    Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal hemochromatosis. Clinical, morphologic, and quantitative iron studies.
    Silver MM; Beverley DW; Valberg LS; Cutz E; Phillips MJ; Shaheed WA
    Am J Pathol; 1987 Sep; 128(3):538-54. PubMed ID: 3307444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal dominant hereditary hemochromatosis associated with two novel Ferroportin 1 mutations in Spain.
    Bach V; Remacha A; Altés A; Barceló MJ; Molina MA; Baiget M
    Blood Cells Mol Dis; 2006; 36(1):41-5. PubMed ID: 16257244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.